Search results
Results from the WOW.Com Content Network
There were around 68,700 drug overdose deaths in the United States in 2018. That is a rate of 210 deaths per million residents. [4] [5] Compare that rate to the 2018 rates of the European countries in the first chart below. Drug overdose death rates for European countries. [15] [16] Location links below are "Healthcare in LOCATION" links.
3 wave of opioid epidemic in the United States. The release of OxyContin marked the beginning of a devastating opioid epidemic, with oxycodone products remaining among the most frequently encountered drugs by law enforcement. [25] From 2011 to 2016, over 33000 overdose deaths in the United States involved the use of oxycodone. [26]
Oxycodone, sold under the brand name Roxicodone and OxyContin (which is the extended-release form) among others, is a semi-synthetic opioid used medically for the treatment of moderate to severe pain. It is highly addictive [14] and is a commonly abused drug.
Deaths from drug overdoses are increasing. Between 2000 and 2014, fatal overdoses rose 137% in the United States, causing nearly half a million deaths in that period, [11] and have also been continually increasing in Australia, [12] Scotland, [13] [14] England, and Wales. [15]
The United States Food and Drug Administration also has a "flush list"; a list of medications that may be safely disposed of by flushing down the toilet. [ 47 ] In the United States, 49 states and the District of Columbia have expanded naloxone access at a pharmacy level via standing order, protocol order, naloxone-specific collaborative ...
The continued prevalence of the opioid epidemic in the United States can be traced to many reasons. For one, there is a lack of appropriate treatments and treatment centers across the nation. [ 39 ] Big cities like New York City are lacking in treatment services and health offices as well as small rural areas . [ 39 ]
The Sackler family’s opioid empire in the United States is collapsing under an avalanche of litigation over marketing tactics. Sales reps at their international affiliate, Mundipharma, have been ...
Oxycodone was first made available in the United States in 1939. In the 1970s, the FDA classified oxycodone as a Schedule II drug, indicating a high potential for non-medical use and addiction. After its 1995 approval by the FDA by Deputy Director Curtis Wright IV , [ 105 ] Purdue Pharma introduced OxyContin, a controlled release formulation of ...